These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23504617)

  • 1. Serum in vivo and in vitro activity of single dose of ertapenem in surgical obese patients for prevention of SSIs.
    de Werra C; Di Micco R; Pilone V; Formato A; Montella E; Lambiase A; Cerbone D; Catania MR; Forestieri P
    Obes Surg; 2013 Jul; 23(7):911-9. PubMed ID: 23504617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Chu Y; Chen S; Cao B; Su J; Duan Q; Zhang S; Shao H; Kong H; Gui B; Hu Z; Badal R; Xu Y
    BMC Infect Dis; 2017 Dec; 17(1):776. PubMed ID: 29254478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
    Kiremitci A; Dinleyici EC; Erben N; Durmaz G; Yargic ZA; Aybey AD; Usluer G
    Expert Opin Pharmacother; 2008 Jun; 9(9):1441-9. PubMed ID: 18518776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the parenteral antibiotic Ertapenem as short term prophylaxis in bariatric surgery: a pharmaco-kinetic-pharmacodynamic study in class III obese female patients.
    Borracci T; Adembri C; Accetta G; Berti J; Cappellini I; Lucchese M; Biggeri A; De Gaudio AR; Novelli A
    Minerva Anestesiol; 2014 Sep; 80(9):1005-11. PubMed ID: 24476845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum beta-lactamase-producing organisms in an intensive care unit.
    Bassetti M; Righi E; Fasce R; Molinari MP; Rosso R; Di Biagio A; Mussap M; Pallavicini FB; Viscoli C
    J Antimicrob Chemother; 2007 Aug; 60(2):433-5. PubMed ID: 17540673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
    Jean SS; Lee WS; Bai KJ; Yu KW; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):290-5. PubMed ID: 25600841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study.
    Leng XS; Zhao YJ; Qiu HZ; Cao YK; Zhu WH; Shen JF; Paschke A; Dai WM; Caldwell N; Wang J
    J Antimicrob Chemother; 2014 Dec; 69(12):3379-86. PubMed ID: 25151205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Surgical Site Infection Following Colorectal Surgery in a Tertiary Center: Extended-spectrum β-Lactamase-producing Bacteria Culprits in Disease.
    Kalakouti E; Simillis C; Pellino G; Mughal N; Warren O; Mills S; Tan E; Kontovounisios C; Tekkis PP
    Wounds; 2017 Dec; 30(4):108-113. PubMed ID: 29718820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANTIBIOTIC PROPHYLAXIS IN BARIATRIC SURGERY: a continuous infusion of cefazolin versus ampicillin/sulbactam and ertapenem.
    Ferraz ÁA; Siqueira LT; Campos JM; Araújo GC; Martins Filho ED; Ferraz EM
    Arq Gastroenterol; 2015; 52(2):83-7. PubMed ID: 26039823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
    Liu HC; Hung YP; Lin HJ; Liu HC; Lee JC; Wu YH; Li CW; Li MC; Ko WC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):584-90. PubMed ID: 26692184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study.
    Branch-Elliman W; Ripollone JE; O'Brien WJ; Itani KMF; Schweizer ML; Perencevich E; Strymish J; Gupta K
    PLoS Med; 2017 Jul; 14(7):e1002340. PubMed ID: 28692690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011.
    Hawser SP; Badal RE; Bouchillon SK; Hoban DJ; Hackel MA; Biedenbach DJ; Goff DA
    J Infect; 2014 Jan; 68(1):71-6. PubMed ID: 24016768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.
    Morrissey I; Bouchillon SK; Hackel M; Biedenbach DJ; Hawser S; Hoban D; Badal RE
    J Med Microbiol; 2014 Apr; 63(Pt 4):556-561. PubMed ID: 24478449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ertapenem for treatment of extended-spectrum beta-lactamase-producing and multidrug-resistant gram-negative bacteraemia.
    Lye DC; Wijaya L; Chan J; Teng CP; Leo YS
    Ann Acad Med Singap; 2008 Oct; 37(10):831-4. PubMed ID: 19037516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgery.
    Zelenitsky SA; Lawson C; Calic D; Ariano RE; Roberts JA; Lipman J; Zhanel GG
    J Antimicrob Chemother; 2016 Oct; 71(10):2902-8. PubMed ID: 27402005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tissue penetration of cefoxitin in obesity: implications for risk of surgical site infection.
    Toma O; Suntrup P; Stefanescu A; London A; Mutch M; Kharasch E
    Anesth Analg; 2011 Oct; 113(4):730-7. PubMed ID: 21642605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.